Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Integrating Electronic Medical Records and Claims Data for Influenza Vaccine Research.
Journal: Vaccines
Published: February 16, 2022
Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 16, 2019
Analysis of the Risks and Benefits of New Chemical Entities Approved by the US Food and Drug Administration (FDA) and Subsequently Withdrawn From the US Market.
Journal: Therapeutic innovation & regulatory science
Published: May 02, 2018
Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.
Journal: Pediatrics
Published: February 01, 2018
Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
Journal: The Journal of infectious diseases
Published: July 31, 2017
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.
Journal: The New England journal of medicine
Published: June 22, 2017
Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
Journal: Vaccine
Published: September 27, 2016
Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.
Journal: Vaccine
Published: June 30, 2015
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.
Journal: Risk analysis : an official publication of the Society for Risk Analysis
Published: April 05, 2013
Last Updated: 09/26/2026